CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 55 filers reported holding CTI BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $709,000 | -3.7% | 1,740,491 | -11.5% | 0.00% | 0.0% |
| Q3 2016 | $736,000 | +587.9% | 1,966,847 | +523.3% | 0.00% | – |
| Q2 2016 | $107,000 | +1683.3% | 315,544 | +2486.4% | 0.00% | – |
| Q1 2016 | $6,000 | -99.5% | 12,200 | -97.8% | 0.00% | -100.0% |
| Q2 2015 | $1,094,000 | -21.1% | 561,124 | -4.6% | 0.00% | -33.3% |
| Q4 2014 | $1,387,000 | -43.3% | 587,916 | -41.8% | 0.00% | -57.1% |
| Q3 2014 | $2,446,000 | +25.7% | 1,010,871 | +45.9% | 0.01% | +40.0% |
| Q2 2014 | $1,946,000 | – | 692,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $18,053,000 | 3.63% |
| Stonepine Capital Management, LLC | 2,617,136 | $1,067,000 | 0.64% |
| FIRST NEW YORK SECURITIES LLC /NY | 35,000 | $14,266,000 | 0.03% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $2,157,000 | 0.02% |
| Caprock Group, LLC | 150,000 | $61,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 334,310 | $136,000 | 0.01% |
| JW Asset Management, LLC | 50,254 | $21,000 | 0.01% |
| Nine Chapters Capital Management LLC | 17,200 | $7,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 60,419 | $24,000 | 0.01% |
| WASHINGTON TRUST Co | 314,000 | $128,000 | 0.01% |